These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25306565)

  • 21. Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study.
    Miwa H; Inoue K; Ashida K; Kogawa T; Nagahara A; Yoshida S; Tano N; Yamazaki Y; Wada T; Asaoka D; Fujita T; Tanaka J; Shimatani T; Manabe N; Oshima T; Haruma K; Azuma T; Yokoyama T;
    Aliment Pharmacol Ther; 2011 Feb; 33(3):323-32. PubMed ID: 21118395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achievements in esophagology during 2008.
    Tytgat GN
    Curr Opin Gastroenterol; 2009 Jul; 25(4):339-41. PubMed ID: 19448532
    [No Abstract]   [Full Text] [Related]  

  • 23. Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?
    Kushner PR; Peura DA
    Adv Ther; 2011 May; 28(5):367-88. PubMed ID: 21484335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.
    Fass R; Inadomi J; Han C; Mody R; O'Neil J; Perez MC
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):247-53. PubMed ID: 22155561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo controlled study for the treatment of symptoms in patients with non-erosive gastroesophageal reflux.
    Palmieri B; Merighi A; Corbascio D; Rottigni V; Fistetto G; Esposito A
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3272-8. PubMed ID: 24379055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolving issues in the management of reflux disease?
    Yuan Y; Hunt RH
    Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance treatment of mild gastroesophageal reflux disease with proton pump inhibitors taken on-demand: a meta-analysis.
    Jiang YX; Chen Y; Kong X; Tong YL; Xu SC
    Hepatogastroenterology; 2013; 60(125):1077-82. PubMed ID: 23803372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dyspepsia and heartburn in primary care: a rational and economic approach].
    Labenz J
    MMW Fortschr Med; 2009 Aug; 151(34-35):47-8. PubMed ID: 19771792
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
    J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of acid-decreasing medication in veteran patients with gastro-oesophageal reflux disorder with and without Barrett's oesophagus.
    El-Serag HB; Wieman M; Richardson P
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1293-9. PubMed ID: 18363892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to differentiate non-erosive reflux disease from functional heartburn.
    Ke MY
    J Dig Dis; 2012 Dec; 13(12):605-8. PubMed ID: 23134478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are you stuck on heartburn medications? Taper off heartburn medications if you are willing to make lifestyle changes to prevent the problem from coming back.
    Harv Mens Health Watch; 2014 Aug; 19(1):5. PubMed ID: 25306577
    [No Abstract]   [Full Text] [Related]  

  • 35. Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study.
    Vakil NB; Huff FJ; Bian A; Jones DS; Stamler D
    Am J Gastroenterol; 2011 Aug; 106(8):1427-38. PubMed ID: 21519360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease.
    Sheikh I; Waghray A; Waghray N; Dong C; Wolfe MM
    Am J Gastroenterol; 2014 Jun; 109(6):789-94. PubMed ID: 24896751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S; Holtmann G
    Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.
    Nocon M; Labenz J; Jaspersen D; Leodolter A; Meyer-Sabellek W; Stolte M; Vieth M; Lind T; Malfertheiner P; Willich SN
    Digestion; 2008; 77(2):69-72. PubMed ID: 18349541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heartburn: in short-term treatment you have the choice!].
    Camain JY; Wiesel PH; Peytremann-Bridevaux I
    Praxis (Bern 1994); 2012 Feb; 101(5):331-2. PubMed ID: 22377981
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular Risk of Proton Pump Inhibitors.
    Ariel H; Cooke JP
    Methodist Debakey Cardiovasc J; 2019; 15(3):214-219. PubMed ID: 31687101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.